Nucleate UK

💫 Nucleate UK is hosting the 3rd Activator Deep Dive: “Advances in Bio-automation” In collaboration with Automata and Bits in Bio, we are holding a panel discussion tackling advances in automation and their applications in research, drug development and synthetic biology. We will be joined by a fantastic line-up of speakers including Satnam Surae, PhD , Co-founder and CTO at twig, Russ Green, Director of Product at Automata, Maureen Makes, Director of Engineering at Recursion and Lilly W., CEO at synteny.ai. The panel will be followed by a networking session with guests and speakers. Sign Up Today: 🔗 https://lu.ma/e429xb00 🗓 Tuesday June 18th, 2024 📌 Bubba Oasis, London

Looking forward to this conversation between Automata Russell Green and Satnam Surae, PhD from twig and Maureen Makes from Recursion on the 18th, if you’re in London come by to talk all things Automation in Bio.

Excited to be at Nucleate UK Forum today! Since James Bayne and I co-founded Nucleate in the UK with the support of the founders and executives Soufiane Aboulhouda Aboulhouda, Oliver Dodd , Mandi Williams , Marissa Pettit Jones, Matthew Lanchantin , Sammi Sison, Michael Retchin and others, less than 3 years ago, the Nucleate has not only become the platform to educate and showcase some of the UK’s most promising student life science entrepreneurs, but also turned into the space for discussions about the future of the UK life science industry and policies that we need to support its further development. As the alum of the Nucleate’s flagship Activator programme, Sensible Biotechnologies is very excited to sponsor The Forum and help provide opportunity for the important conversations about the life science industry in the UK. I am excited to discuss the story of Sensible and the early-stage life science entrepreneurship with Vishal Gulati, Managing Partner at Recode Ventures, one of the icons of early-stage and founder-friendly life-science investing, and with Amit Halkhoree, Nucleate UK’s National Director of Communications. We are excited to listen to and learn from leading figures in the European and UK life science ecosystem, including Lorenz Mayr, Molly Stevens, David Roblin and many others. Many thanks to amazing Nucleate UK team, especially James, Federico Caso, Maja Wojtynska, Alya M., Jamie Rintoul, Abhimanyu Gowda and many others, as well as BlueYard Capital, BACKED VC, and many other Nucleate UK sponsors, who made this event possible. #nucleateuk #nucleate #theforum #sensible #founderledbio

 🌟 Exciting Insights from the "Sequencing Technologies" Event! 🌟 Hosted by Nucleate UK x IQ Capital and Valence Labs, our recent event on sequencing technologies was a powerhouse of knowledge and innovation. Here are the key takeaways:  📊 Data Abundance vs. Patient-Specific Insights: While we have ample data for fundamental biological research, there’s still a gap in patient-specific insights. The consensus? Yes, we have enough data for algorithms to extract more insights, but patient-specific nuances need more work.  🔬 Innovations in Sample Prep: Often overlooked, but essential. Companies like Oxford Nanopore Technologies are making headway in minimising prep for in situ sequencing, enhancing efficiency and accuracy. 👩🔬  Epigenetics on the Rise: Epigenetics will play an increasingly significant role in sequencing and its diverse applications. 🌍  Beyond Human Health: The potential of cheaper sequencing extends far beyond human health, including pandemic prevention, environmental monitoring, veterinary care, and more. A big thank you to all the speakers Mark Bruce (Oxford Nanopore Technologies), Alisandra Denton (Valence Labs), Debora Lucarelli (Tagomics) and Peter Crane (Caeruleus Genomics) for an enlightening session! Let's continue pushing the boundaries of sequencing technologies. 

We are thrilled to announce our support for Nucleate UK and their incredible initiative, The Forum. This invite-only gathering brings together visionary founders, pharma executives, savvy investors, and forward-thinking policymakers to drive innovation in the life sciences sector. #HlxLifeSciences #NucleateForum #LifeSciencesInnovation #Pharma #Biotech #Healthcare #Investment #Innovation #Networking

Really excited for the next iteration of our Nucleate UK and IQ Capital technology deep dives - this time focussing on the future of sequencing technologies. We have some amazing speakers lined up and only limited spots still available, so sign up soon! Huge thanks to Valence Labs for hosting this one.

🚀Join us for the 2nd Activator Deep Dive Session next week: Hosted by IQ Capital and Valence Labs - Learn about next-gen sequencing tech from a panel of leaders from Tagomics, Caeruleus Genomics, Oxford Nanopore Technologies, and Valence Labs 🗓 WHEN: May 28th 6:30 - 9:30 PM 📍 WHERE: London 🔗 Register Now - https://lu.ma/xfa8h525 Thanks to our sponsors IQ Capital & Valence Labs! 

The Forum: an invite-only gathering of founders, pharma executives, investors and policymakers - apply for one of our limited public spaces to be a part of it today: https://lnkd.in/eiCdDKP8 Nucleate #biotech #innovation

The Forum: an invite-only gathering of founders, pharma executives, investors and policymakers - apply for one of our limited public spaces to be a part of it today: https://lnkd.in/eiCdDKP8 Nucleate #biotech #innovation

🚀 Nucleate x IQ Capital: Next Generation Sequencing Technologies 🚀 We're thrilled to unite the UK's Sequencing community for an evening of game-changing insights and vibrant networking! The UK holds a proud legacy in sequencing, dating back to the invention of Sanger sequencing in Cambridge—a revolutionary technique that shaped modern genomics. Companies like Solexa and Oxford Nanopore Technologies have since pushed the field further, transforming the way we analyse and understand genetic information. Join us to explore the next generation of sequencing technologies with our fantastic line-up of speakers including Debora Lucarelli, Peter Crane and Alisandra Denton. Together, we'll delve into cutting-edge innovations, tackle bottlenecks, and ignite conversations on new science and tech poised to redefine the field. Connect with like-minded professionals, gain valuable insights, and help shape the future of sequencing solutions. 🏁 Key Event Details 🏁 🗓 Tuesday, May 28th 🔗 RSVP Here - https://lu.ma/xfa8h525 #SequencingTech #Innovation #UKSequencingHistory